From the editor.
Myron H
MH
Weinberger
D000818:Animals; D001794:Blood Pressure; D015740:Calcitonin Gene-Related Peptide / Q000235:genetics; D004562:Electrocardiography; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D051436:Renal Insufficiency, Chronic / Q000503:physiopathology; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D014463:Ultrasonography
D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D015740:Calcitonin Gene-Related Peptide